Independent
Tenure on this board
4.2 yrs
Meeting calendar
IVVD · Annual meeting · Tuesday, May 19, 2026
Invivyd Inc
6 nominees · 2 ballot items.
Election of six director nominees for a one-year term and ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Market cap
$218M
1Y TSR
-12.7%
Board grade
C-
Record date
Mar 20, 2026
Filing
DEF 14A
Meeting concluded · May 19, 2026
Follow how the vote landed and what changed on Invivyd Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot2
- 1
Election of six directors
ManagementBoard: FORElection of six director nominees named in the Proxy Statement for a one-year term expiring at the 2027 Annual Meeting.
- 2
Ratification of appointment of independent registered public accounting firm
ManagementBoard: FORRatification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Director elections
Nominees on the ballot6
Independent
Tenure on this board
0.9 yrs
Also a director at
Wave Life Sciences Ltd (WVE)
Independent
Tenure on this board
4.2 yrs
Also a director at
Fractyl Health Inc (GUTS)
Independent
Tenure on this board
5.0 yrs
Also a director at
Seer Inc (SEER)
Independent
Tenure on this board
2.3 yrs
Also a director at
Vericel Corp (VCEL)
Independent
Tenure on this board
1.4 yrs
Also a director at
Fractyl Health Inc (GUTS)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Jupiter Topco LLC | 11.6% | 34,173,104 | $30M |
| 2 | BVF INC/IL | 9.6% | 28,165,000 | $25M |
| 3 | MAVERICK CAPITAL LTD | 6.4% | 18,970,913 | $17M |
| 4 | PERCEPTIVE ADVISORS LLC | 6.3% | 18,490,636 | $16M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 10,496,507 | $9M |
| 6 | M28 Capital Management LP | 3.1% | 9,248,250 | $8M |
| 7 | BlackRock, Inc. | 3.0% | 8,709,497 | $8M |
| 8 | Saturn V Capital Management LP | 2.8% | 8,392,288 | $7M |
| 9 | Soleus Capital Management, L.P. | 2.6% | 7,708,727 | $7M |
| 10 | Point72 Asset Management, L.P.Activist | 2.6% | 7,542,061 | $7M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Invivyd Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Anavex Life Sciences CorpAVXL
Annual meeting·Sep 24, 2026·$298M
Simulations Plus IncSLP
Special meeting·Aug 27, 2026·$371M
Canopy Growth CorpCGC
Annual meeting·Sep 25, 2026·$423M
Ocugen IncOCGN
Special meeting·Sep 21, 2026·$466M
Artiva Biotherapeutics IncARTV
Annual meeting·Sep 8, 2026·$574M
Replimune Group IncREPL
Annual meeting·Sep 15, 2026·$1.4B
Reference
Frequently asked questions
- When is the Invivyd Inc 2026 annual meeting?
- Invivyd Inc (IVVD) holds its 2026 annual shareholder meeting on Tuesday, May 19, 2026.
- What is the record date for the Invivyd Inc 2026 meeting?
- The record date for the Invivyd Inc 2026 meeting is Friday, March 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Invivyd Inc's 2026 meeting?
- The board is presenting 6 director nominees at the Invivyd Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Invivyd Inc 2026 meeting?
- Shareholders will vote on 2 proposals at the Invivyd Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.